PharmaCielo Ltd. (PCLOF) Stock
PharmaCielo Ltd., operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition, the company provides telemedicine software solutions.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About PharmaCielo Ltd.
PharmaCielo Ltd., operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition, the company provides telemedicine software solutions. Its diverse clientele comprises health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies across Canada and Colombia. PharmaCielo Ltd. maintains a strategic alliance with AssuredTrans Inc., and its corporate headquarters are located in Toronto, Canada.
PharmaCielo Ltd. is headquartered in CA.
PharmaCielo Ltd. (PCLOF) stock trades at $0.05 with a market capitalization of $9.02M. The stock is valued at a price-to-earnings (P/E) ratio of -3.23, price-to-book of -1.09, price-to-sales of 4.45. Over the past 52 weeks the stock has ranged between $0.00 and $0.12, and currently trades 58.3% below its 52-week high.
On profitability, PharmaCielo Ltd. generates a return on equity (ROE) of 27.36% — well above the market average, a sign of a high-quality business, return on capital employed of 29.45%, an operating margin of -127.52%, a net profit margin of -141.06%.
Official website: www.pharmacielo.com